logo

Jesse Ory, Kyle Lehmann and Jeff Himmelman Department of Urology, Dalhousie University Halifax, NS, Canada Abstract Objectives To describe the technique of robot-assisted high-exte[...]
Having trained and worked in London throughout my urology career, I have recently relocated and joined the exciting, dynamic urology community of my birthplace, Hong Kong. Coincide[...]
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full arti[...]
The use of active surveillance (AS) is rapidly expanding worldwide, with rates as high as 74% among patients with low-risk prostate cancer in the nationwide registry of Sweden [1].[...]
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance Mufaddal M. Mamawala, Karthik Rao, Patricia Landis, Jonathan I. [...]
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full arti[...]
In January 2016, in his final State of the Union address, US President Barack Obama tasked Vice President Joseph Biden with heading up a new national mission, the Cancer Moonshot, [...]
Qualitative study on decision-making by prostate cancer physicians during active surveillance Stacy Loeb*,†,‡,§, Caitlin Curnyn†, Angela Fagerlin¶,**, Ronald Scott Braithwaite† Mar[...]
The much awaited results of the STAMPEDE study of abiraterone for hormone naive prostate cancer was simultataneously presented at #ASCO17 and published ‘on line ahead of prin[...]